Hologic Recall Triggers US Shortage of Breast Biopsy Needles, FDA Says
2026-06-17 17:09:31
The US Food and Drug Administration said the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year. According to Bloomberg, the shortage could delay breast cancer diagnoses for some patients.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Polymarket Bettors Lose Millions After Spain Draws Cape Verde 0-0Next article：
意大利金融科技Conio获MiCAR牌照
